Literature DB >> 17102097

The effects of urotensin-II on proliferation of pheochromocytoma cells and mRNA expression of urotensin-II and its receptor in pheochromocytoma tissues.

Zheng-Pei Zeng1, Guo-Qiang Liu, Han-Zhong Li, Xin-Rong Fan, Dong-Mei Liu, An-Li Tong, Xin Zheng, Chang Liu.   

Abstract

This study was conducted to investigate the effects of urotensin-II (UII) on the proliferation of pheochromocytoma cells and the mRNA expression of UII and its receptor G protein-coupled receptor 14 (GPR14) in normal adrenal and human pheochromocytoma tissues. The effects on the cell proliferation by different UII concentrations and at different time were observed with the MTT method in both rat pheochromocytoma cell line (PC12 cell) and human pheochromocytoma cells. The mRNA expression of UII and GPR14 was evaluated by RT-PCR. UII had no significant effect on the proliferation in PC12 cells, but promoted the proliferation of human pheochromocytoma cells. The mRNA expression of UII and GPR14 in pheochromocytoma was lower than that in normal adrenal tissues. But mRNA expression of UII and GPR14 in adrenal pheochromocytomas was lower than that in extra-adrenal pheochromocytomas. Thus, UII and its receptor GPR14 exert a possible effect in the pathogenesis of pheochromocytoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17102097     DOI: 10.1196/annals.1353.032

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

1.  Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis.

Authors:  Arnold S Kristof; Zhipeng You; Yin-Shan Han; Adel Giaid
Journal:  Peptides       Date:  2010-04-28       Impact factor: 3.750

2.  The relationship between urotensin II and its receptor and the clinicopathological parameters of breast cancer.

Authors:  Ozan Balakan; Mehmet Emin Kalender; Ali Suner; Beyhan Cengiz; Serdar Oztuzcu; Recep Bayraktar; Ersin Borazan; Taner Babacan; Celaletdin Camci
Journal:  Med Sci Monit       Date:  2014-08-12

3.  Urotensin II Exerts Pressor Effects By Stimulating Renin And Aldosterone Synthase Gene Expression.

Authors:  Brasilina Caroccia; Mirko Menegolo; Teresa M Seccia; Lucia Petrelli; Michele Antonello; Alice Limena; Andrea Porzionato; Raffaele De Caro; Marko Poglitsch; Gian Paolo Rossi
Journal:  Sci Rep       Date:  2017-10-24       Impact factor: 4.379

4.  Up-regulation of urotensin II and its receptor contributes to human hepatocellular carcinoma growth via activation of the PKC, ERK1/2, and p38 MAPK signaling pathways.

Authors:  Xiao-Tong Yu; Peng-Yan Wang; Zheng-Ming Shi; Kun Dong; Ping Feng; Hong-Xia Wang; Xue-Jiang Wang
Journal:  Molecules       Date:  2014-12-12       Impact factor: 4.411

5.  Mutation profiling in eight cases of vagal paragangliomas.

Authors:  Anna V Kudryavtseva; Dmitry V Kalinin; Vladislav S Pavlov; Maria V Savvateeva; Maria S Fedorova; Elena A Pudova; Anastasiya A Kobelyatskaya; Alexander L Golovyuk; Zulfiya G Guvatova; George S Razmakhaev; Tatiana B Demidova; Sergey A Simanovsky; Elena N Slavnova; Andrey А Poloznikov; Andrey P Polyakov; Nataliya V Melnikova; Alexey A Dmitriev; George S Krasnov; Anastasiya V Snezhkina
Journal:  BMC Med Genomics       Date:  2020-09-18       Impact factor: 3.063

6.  Urotensin-II-Mediated Reactive Oxygen Species Generation via NADPH Oxidase Pathway Contributes to Hepatic Oval Cell Proliferation.

Authors:  XiaoTong Yu; PengYan Wang; ZhengMing Shi; Kun Dong; Ping Feng; HongXia Wang; XueJiang Wang
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

7.  Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2.

Authors:  Alexander A Goldberg; Kwang-Bo Joung; Asma Mansuri; Yujin Kang; Raquel Echavarria; Ljiljana Nikolajev; Yang Sun; Jane J Yu; Stephane A Laporte; Adel Schwertani; Arnold S Kristof
Journal:  Oncotarget       Date:  2016-09-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.